+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Cell Banking Market Trends, Opportunities, and Future

  • ID: 4035765
  • Report
  • Region: Global
  • 51 Pages
  • Frost & Sullivan
1 of 2
As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding their Service Portfolio and Collaborating with Biopharmaceutical Companies

This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by specialized and technologically advanced services offered by CROs/CMOs, growing demand for gene and cell therapy, and increased partnerships with biopharmaceutical companies. Also, there are an increasing number of grants, incentives, and private investments in research on cell therapeutics and biopharmaceuticals. Master cell banking and storage accounted for the largest shares of cell banking revenue, among the different bank types, and the different phases of cell banking, respectively, in 2015.

The study also provides market forecasts for cell line development, a preliminary step to cell banking. Cell line development is driven by technological advancements and increasing demand for cancer therapeutics and monoclonal antibodies. Mammalian cell lines are the most used source for cell line development in all regions. The United States leads in cell line development and cell banking, closely followed by Europe and Asia-Pacific. The fastest growth rate was experienced in Asia-Pacific, with the hotbeds in India and China. Due to increasing demand for cell lines and cell banking, CMOs/CROs are focusing on providing end-to-end services by expanding their service portfolio and collaborating with biopharmaceutical companies.

Note: Product cover images may vary from those shown
2 of 2
1. Executive Summary
  • Key Findings
  • Scope and Segmentation
  • Market Overview
  • Market Revenue Forecasts Snapshot
  • Market Trends
  • Industry Value Chain
  • 8 Big Market Themes for Cell Banking
2. Market Overview
  • Global Market Perspective
3. In-house and Outsourced Cell Banking
  • In-house and Outsourced Cell Banking-Large Pharma
  • In-house and Outsourced Cell Banking-Generic Pharma
  • In-house and Outsourced Cell Banking-Biotech
  • In-house and Outsourced Cell Banking
  • Out-sourced Cell Banking Trends
4. Regional Trends
  • Regional Trends in the Cell Banking Market
5. Drivers and Restraints-Cell Banking Market
  • Market Drivers
  • Drivers Explained
  • Market Restraints
  • Restraints Explained
6. Forecasts and Trends
  • Market Revenue Forecasts Approach
  • Cell Line Development Market-Revenue Forecast
  • Revenue Forecast Discussion
  • Cell Banking Market-Revenue Forecast
  • Revenue Forecast Discussion
  • Biologics Safety Testing Market-Revenue Forecast
  • Revenue Forecast Discussion
7. Growth Opportunities and Companies to Action
  • Transformation in Pharmaceutical Industry Eco-system
  • 4 Major Growth Opportunities
  • Strategic Imperatives for CMOs and CROs
Note: Product cover images may vary from those shown
3 of 2